Clindamycin In 5 Percent Dextrose Injection, Solution
Product Images NDC 0143-9267

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Clindamycin In 5 Percent Dextrose (NDC 0143-9267). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Clindamycin In 5 Percent Dextrose Injection 1)

Chemical structure of clindamycin, as presented in the image for Clindamycin in 5 percent Dextrose intravenous injection by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

300mg Vial (Clindamycin In 5 Percent Dextrose Injection 2)

Clindamycin in 5% Dextrose Injection 300 mg per 50 mL (6 mg/mL) single-dose vial label. For intravenous use, sterile and nonpyrogenic. Contains clindamycin phosphate and dextrose monohydrate. Label includes storage instructions, cautionary notes, and manufacturing details from Hikma Pharmaceuticals USA Inc.*

FDA Label Image

600mg Vial (Clindamycin In 5 Percent Dextrose Injection 3)

Label for Clindamycin in 5% Dextrose Injection, 600 mg per 50 mL (12 mg/mL) intravenous solution. The label shows this is a single-dose vial of 50 mL, sterile, nonpyrogenic, supplied by Hikma Pharmaceuticals USA Inc. It includes cautions for intravenous use only, storage instructions between 20° to 25°C, and directions to check accompanying prescribing information for dosage.*

FDA Label Image

900mg Vial (Clindamycin In 5 Percent Dextrose Injection 4)

Clindamycin in 5 percent Dextrose Injection 900 mg per 50 mL (18 mg/mL) single-dose vial label. The label states it is for intravenous use, sterile and nonpyrogenic, containing clindamycin phosphate and dextrose monohydrate with other components. The label includes storage instructions, usage cautions, and the labeler Hikma Pharmaceuticals USA Inc., with manufacturing and distribution information.*

FDA Label Image

Serialization (Clindamycin In 5 Percent Dextrose Injection 5)

A label featuring a QR code on the left and a barcode with numbers below it on the right. Above the barcode are printed identifiers including GTIN, serial number, expiration date, and lot number. The label does not display any proprietary or generic product names or dosage form information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.